To detect the gravitational-wave (GW) signal from binary neutron stars and extract information about the equation of state of matter at nuclear density, it is necessary to match the signal with a bank of accurate templates. We present the two longest (to date) general-relativistic simulations of equal-mass binary neutron stars with different compactnesses, C=0.12 and C=0.14, and compare them with a tidal extension of the effective-one-body (EOB) model. The typical numerical phasing errors over the ≃22 GW cycles are Δϕ≃±0.24 rad. By calibrating only one parameter (representing a higher-order amplification of tidal effects), the EOB model can reproduce, within the numerical error, the two numerical waveforms essentially up to the merger. By contrast, the third post-Newtonian Taylor-T4 approximant with leading-order tidal corrections dephases with respect to the numerical waveforms by several radians.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1103/PhysRevLett.105.261101 | DOI Listing |
Inorg Chem
January 2025
Radiation Science & Technology Department, Faculty of Applied Sciences, Delft University of Technology, Mekelweg 15, Delft 2629JB, The Netherlands.
The detailed crystal structure as well as the heat capacity at low temperature and standard entropy of BaMoO are reported for the first time. High-resolution X-ray and neutron diffraction were employed to reveal the structural features of this compound. BaMoO has a six-coordinated Mo and a strongly negative excess volume with respect to the binary oxides.
View Article and Find Full Text PDFJ Colloid Interface Sci
December 2024
Department of Medicinal Chemistry, Uppsala University, P.O. Box 547, 751 23, Uppsala, Sweden. Electronic address:
We have investigated the effect of length and chemical structure of phospholipid tails on the spontaneous formation of unilamellar liposomal vesicles in binary solute mixtures of cationic drug surfactant and zwitterionic phosphatidylcholine phospholipids. Binary drug surfactant-phospholipid mixtures with four different phospholipids with identical headgroups (two saturated phospholipids 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC, 14:0) and 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, 16:0), and two unsaturated lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, 18:1) and 1,2-Dierucoyl-sn-Glycero-3-Phosphatidylcholine (DEPC, 22:1)) combined with two different tricyclic antidepressant drugs (amitriptyline hydrochloride (AMT) and doxepin hydrochloride (DXP)) have been investigated with small-angle neutron scattering (SANS) and cryo-transmission electron microscopy (cryo-TEM). We observe a conspicuous impact of phospholipid tail structure on both micelle-to-vesicle transition point and vesicle size.
View Article and Find Full Text PDFInorg Chem
December 2024
Department of Chemistry, University of Toronto, 80 Saint George Street, Toronto, Ontario M5S-3H6, Canada.
Here it is demonstrated that there is a linear relationship between the terminal 3d metal hydride stretching wavenumber ν and the metal hydride distance reported to date: ν ∼ (-1.05 + 3.35) × 10 cm.
View Article and Find Full Text PDFProc SPIE Int Soc Opt Eng
February 2024
Radiation Monitoring Devices, Inc., 44 Hunt St., Watertown, MA, USA 02472- 4624.
Development of new scintillator materials is a continuous effort, which recently has been focused on materials with higher stopping power. Higher stopping power can be achieved if the compositions include elements such as Tl (Z=81) or Lu (Z=71), as the compounds gain higher densities and effective atomic numbers. In context of medical imaging this translates into high detection efficiency (count rates), therefore, better image quality (statistics, thinner films) or lower irradiation doses to patients in addition to lowering of cost.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
November 2024
The Radiology Department of Shanxi Provincial People's Hospital Affiliated to, Shanxi Medical University, Taiyuan, 030001, P. R. China.
Boron neutron capture therapy (BNCT) is an advanced binary tumor-cell-selected heavy-particle radiotherapy used for treating invasive malignant tumors. However, its clinical applications have been impeded by the rapid metabolism and insufficient tumor-specific accumulation of boron agents. To tackle this issue, we develop a smart boron nanosensitizer (BATBN) capable of transforming its size in response to cancer biomarker for optimal balance between penetration and retention of boron-10 for BNCT.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!